Published in BMJ on January 08, 2013
The growth of acute kidney injury: a rising tide or just closer attention to detail? Kidney Int (2014) 1.80
A few clarifications please. BMJ (2013) 1.06
Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study. Am J Kidney Dis (2014) 1.04
Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney Int (2015) 1.00
ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study. PLoS One (2013) 0.97
Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag (2015) 0.96
Primary care physicians' familiarity, beliefs, and perceived barriers to practice guidelines in non-diabetic CKD: a survey study. BMC Nephrol (2014) 0.85
Evaluating ethnic differences in the prescription of NSAIDs for chronic kidney disease: a cross-sectional survey of patients in general practice. Br J Gen Pract (2014) 0.81
Acute kidney injury: an acceptable risk of treatment with renin-angiotensin system blockade in primary care? Can J Kidney Health Dis (2015) 0.81
Prediction and Prevention of Acute Kidney Injury after Cardiac Surgery. Biomed Res Int (2016) 0.81
NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species. Oxid Med Cell Longev (2015) 0.80
Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice. Br J Clin Pharmacol (2015) 0.80
Safety issues of current analgesics: an update. Clujul Med (2015) 0.80
The risks and benefits of patients temporarily discontinuing medications in the event of an intercurrent illness: a systematic review protocol. Syst Rev (2015) 0.78
Nonpharmacological strategies to prevent contrast-induced acute kidney injury. Biomed Res Int (2014) 0.78
Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study. BMJ Open (2016) 0.77
Safety of Fixed Dose of Antihypertensive Drug Combinations Compared to (Single Pill) Free-Combinations: A Nested Matched Case-Control Analysis. Medicine (Baltimore) (2015) 0.77
The nephrotoxic "triple whammy" of combining diuretics, ACE inhibitors, and NSAIDs [corrected]. BMJ (2013) 0.77
Validity of ankylosing spondylitis diagnoses in The Health Improvement Network. Pharmacoepidemiol Drug Saf (2016) 0.77
The impact of adherence to inhaled drugs on 5-year survival in COPD patients: a time dependent approach. Pharmacoepidemiol Drug Saf (2016) 0.77
Postoperative acute kidney injury. Korean J Anesthesiol (2017) 0.77
Acute Kidney Injury Treated with Dialysis outside the Intensive Care Unit: A Retrospective Observational Single-Center Study. PLoS One (2016) 0.77
What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis. BMJ Open (2017) 0.75
The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database. Br J Clin Pharmacol (2016) 0.75
Safe use of NSAIDs and RAS-inhibitors at Agogo Presbyterian Hospital, Ghana. Ghana Med J (2016) 0.75
Use of diuretics with ACE inhibitors or angiotensin receptor blockers and NSAIDs increases the risk of acute kidney injury. Evid Based Med (2013) 0.75
The very high premature mortality rate among active professional wrestlers is primarily due to cardiovascular disease. PLoS One (2014) 0.75
Acute tubulointerstitial nephritis/drug induced acute kidney injury; an experience from a single center in Pakistan. J Renal Inj Prev (2016) 0.75
Safety concerns in simultaneous use of prescription and 'over-the-counter' medicines- results of patient survey in Estonia. Springerplus (2014) 0.75
The PanAM study: a multi-center, double-blinded, randomized, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emerg Med (2013) 0.75
Authors' reply to Moore. BMJ (2013) 0.75
More evidence of nephrotoxicity with renin-angiotensin-aldosterone system blockers. BMJ (2013) 0.75
Simvastatin dose and acute kidney injury without concurrent serious muscle injury: A nationwide nested case-control study. PLoS One (2017) 0.75
Practical approach to detection and management of acute kidney injury in critically ill patient. J Intensive Care (2017) 0.75
Herbal formula SC-E1 suppresses lipopolysaccharide-stimulated inflammatory responses through activation of Nrf2/HO-1 signaling pathway in RAW 264.7 macrophages. BMC Complement Altern Med (2017) 0.75
Drug-Induced Kidney Injury in the Elderly. Drugs Aging (2017) 0.75
Hyperuricemia, Type 2 Diabetes Mellitus, and Hypertension: an Emerging Association. Curr Hypertens Rep (2017) 0.75
[Dosage and toxicity of antirheumatic drugs in renal insufficiency]. Z Rheumatol (2015) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol (2003) 11.24
Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol (2010) 10.70
Hospital-acquired renal insufficiency. Am J Kidney Dis (2002) 7.90
Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol (1998) 7.41
Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract (2010) 7.41
Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol (2005) 6.27
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int (2009) 5.28
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol (2006) 4.95
Community-based incidence of acute renal failure. Kidney Int (2007) 4.22
Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med (2002) 3.57
Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol (1999) 3.44
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation (2009) 3.39
Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol (2009) 3.28
Statistics in epidemiology: the case-control study. J Am Stat Assoc (1996) 3.28
Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction. JAMA (2010) 2.44
Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages. Nat Clin Pract Rheumatol (2007) 2.18
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98
Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol (2011) 1.94
Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am J Med (1987) 1.93
Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis (2005) 1.89
Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med (1996) 1.87
Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant (2012) 1.83
Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs. Am J Med (2001) 1.74
Immeasurable time bias in observational studies of drug effects on mortality. Am J Epidemiol (2008) 1.73
Validity of administrative database coding for kidney disease: a systematic review. Am J Kidney Dis (2011) 1.73
Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes. Circulation (2007) 1.70
Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis. Am J Epidemiol (2006) 1.59
Drug-induced acute kidney injury. Curr Opin Crit Care (2005) 1.42
Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf (2007) 1.39
Physiology of renal sodium transport. Am J Med Sci (2000) 1.37
Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009. J R Soc Med (2010) 1.36
Diuretics, ACE inhibitors and NSAIDs--the triple whammy. Med J Aust (2000) 1.35
Acute renal failure of medical type in an elderly population. Nephrol Dial Transplant (1998) 1.23
Drug combinations and impaired renal function -- the 'triple whammy'. Br J Clin Pharmacol (2005) 1.22
Patients are dying of acute renal failure. Crit Care Med (2002) 1.19
Drug-induced renal disease. Med J Aust (1992) 1.15
Nephrotoxicity in the elderly due to co-prescription of angiotensin converting enzyme inhibitors and nonsteroidal anti-inflammatory drugs. J R Soc Med (2001) 1.05
The epidemiology of drug-induced disorders: the kidney. Expert Opin Drug Saf (2008) 1.04
Risk of acute renal failure in patients with Type 2 diabetes mellitus. Diabet Med (2012) 1.03
Peeking into the black box: new biomarkers for acute kidney injury. Kidney Int (2008) 1.00
Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography. J Nephrol (2012) 0.99
Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury. Pharmacoepidemiol Drug Saf (2009) 0.99
The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects. Eur J Clin Pharmacol (2006) 0.95
Confounding by contraindication in a nationwide cohort study of risk for death in patients taking ibopamine. Ann Intern Med (2001) 0.94
Opportunities for minimization of confounding in observational research. Pharm Stat (2011) 0.92
Patient-reported communications with pharmacy staff at community pharmacies: the Alabama NSAID Patient Safety Study, 2005-2007. J Am Pharm Assoc (2003) (2010) 0.92
Exposure of the elderly to potential nephrotoxic drug combinations in Belgium. Pharmacoepidemiol Drug Saf (2008) 0.91
Antidepressant use and cognitive deficits in older men: addressing confounding by indications with different methods. Ann Epidemiol (2011) 0.87
Assessing the effects of non-steroidal anti-inflammatory drugs on antihypertensive drug therapy using post-marketing surveillance database. J Epidemiol (2008) 0.87
Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire. J Hypertens (2010) 0.84
Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients. Am J Health Syst Pharm (2010) 0.83
Acute renal failure. Am Fam Physician (2007) 0.83
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA (2005) 6.87
Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med (2009) 6.75
Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med (2007) 6.23
Use of statins and the risk of death in patients with prostate cancer. J Clin Oncol (2013) 5.28
Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med (2007) 3.94
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study. BMJ (2012) 3.82
Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry (2009) 3.33
Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ (2006) 3.18
Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer. JAMA (2013) 3.16
Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care (2012) 3.11
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ (2010) 3.09
A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther (2008) 2.87
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology (2008) 2.87
Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan cohort study. Chest (2012) 2.65
ACE-I and ARBs in early diabetic nephropathy. J Renin Angiotensin Aldosterone Syst (2002) 2.64
The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol (2008) 2.60
Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. BMJ (2010) 2.40
Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation (2006) 2.34
Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis (2006) 2.29
Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis (2012) 2.17
The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum (2007) 2.16
Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ (2007) 2.02
Cardiovascular morbidity and mortality in COPD. Chest (2005) 2.01
Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs. Pharmacoepidemiol Drug Saf (2007) 1.98
Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Arch Pediatr Adolesc Med (2007) 1.96
Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J (2008) 1.94
Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ (2008) 1.91
Natural history of multiple sclerosis with childhood onset. N Engl J Med (2007) 1.89
The nested case-control study in cardiology. Am Heart J (2003) 1.84
Gender differences in survival following hospitalisation for COPD. Thorax (2010) 1.73
Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States. Am J Obstet Gynecol (2008) 1.71
The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes (2005) 1.67
The use of inhaled corticosteroids and the risk of adrenal insufficiency. Eur Respir J (2012) 1.67
The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation. Thromb Haemost (2013) 1.53
When and by whom is concern first expressed for children with neuromotor problems? Arch Pediatr Adolesc Med (2005) 1.51
Acute effects of exercise in patients with previous deep venous thrombosis: impact of the postthrombotic syndrome. Chest (2003) 1.49
Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol (2006) 1.49
First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr (2004) 1.48
The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol (2004) 1.44
Use of lithium and the risk of injurious motor vehicle crash in elderly adults: case-control study nested within a cohort. BMJ (2004) 1.44
Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis (2012) 1.43
The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care (2012) 1.42
Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort. Chest (2012) 1.42
The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study. Diabetes (2005) 1.40
Metformin and the incidence of prostate cancer in patients with type 2 diabetes. Cancer Epidemiol Biomarkers Prev (2010) 1.39
Antibiotics in primary prevention of stroke in the elderly. Stroke (2003) 1.39
Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study. Stroke (2006) 1.38
Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer. Eur Urol (2011) 1.37
Point: were industry-sponsored roflumilast trials appropriate? Yes. Chest (2014) 1.36
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ (2010) 1.32
MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain (2004) 1.31
Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study. BMJ (2014) 1.27
The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.24
Effect of fear of litigation on obstetric care: a nationwide analysis on obstetric practice. Am J Perinatol (2011) 1.23
Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol (2008) 1.23
Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med (2013) 1.22
The case-crossover study design in pharmacoepidemiology. Stat Methods Med Res (2008) 1.21
Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. JAMA Intern Med (2016) 1.21
Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. Pharmacoepidemiol Drug Saf (2009) 1.19
Mortality after infection with methicillin-resistant Staphylococcus aureus (MRSA) diagnosed in the community. BMC Med (2008) 1.18
Changes in patient and technique survival over time among incident peritoneal dialysis patients in Canada. Clin J Am Soc Nephrol (2012) 1.14
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br J Clin Pharmacol (2007) 1.13
Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med (2010) 1.12
Lifestyle variables and the risk of myocardial infarction in the general practice research database. BMC Cardiovasc Disord (2007) 1.12
Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada. Arthritis Rheum (2009) 1.10
Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med (2008) 1.09
Resumption of warfarin therapy after gastrointestinal tract bleeding: benefit or bias? JAMA Intern Med (2013) 1.08
Pregnancy-associated breast cancer: a review for the obstetrical care provider. J Obstet Gynaecol Can (2011) 1.08
Secular trends of antibacterial prescribing in UK paediatric primary care. J Antimicrob Chemother (2010) 1.08
Body mass index (BMI) and waist circumference (WC) as screening tools for cardiovascular risk factors in Guadeloupean women. J Clin Epidemiol (2002) 1.06
Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK. Emerg Infect Dis (2007) 1.06
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses. Arthritis Res Ther (2011) 1.04
Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol (2008) 1.02
Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain (2007) 1.01
Demyelinating events in rheumatoid arthritis after drug exposures. Ann Rheum Dis (2009) 1.00
Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST). Am J Obstet Gynecol (2005) 1.00
Warfarin use and the risk of motor vehicle crash in older drivers. Br J Clin Pharmacol (2006) 1.00
Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes (2003) 0.99
Heme oxygenase-1 upregulation significantly inhibits TNF-alpha and Hmgb1 releasing and attenuates lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol (2008) 0.99
Anti-diabetic drug use and the risk of motor vehicle crash in the elderly. Can J Clin Pharmacol (2006) 0.98
Exclusion of immortal person-time. Pharmacoepidemiol Drug Saf (2008) 0.98
Prognosis of pulmonary arterial hypertension: the power of clinical registries of rare diseases. Circulation (2010) 0.98
Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment. Arthritis Res Ther (2010) 0.97
Predicting disease-associated substitution of a single amino acid by analyzing residue interactions. BMC Bioinformatics (2011) 0.97
An impact evaluation of the Safe Motherhood Program in China. Health Econ (2010) 0.96
Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum (2009) 0.96
Simvastatin in moderate-to-severe COPD. N Engl J Med (2014) 0.96
Epidemiology of inflammatory bowel disease in Québec: recent trends. Inflamm Bowel Dis (2014) 0.96
The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study. Ophthalmology (2006) 0.96